Thermo Fisher Scientific Inc. and QIAGEN N.V. announced that they have entered into an amendment to their acquisition agreement under which Thermo Fisher has commenced a tender offer to acquire all of the ordinary shares of QIAGEN. The amendment provides for an increase from the original of ... more
Thermo Fisher Scientific and Immundiagnostik Collaborate To Develop Mass Spectrometry-Based Clinical and Research Tools
Thermo Fisher Scientific, Inc. and Immundiagnostik AG announced a collaboration to develop novel mass spectrometry-based assays for qualitative and quantitative analysis of proteins and peptides. The goal is development of commercial assays to be widely applicable in research and routine clinical analysis.
The collaboration will focus on advancing biomarker research by combining Immundiagnostik’s ImmunoTube® antibody technology with Thermo Fisher’s new liquid chromatography-triple quadrupole mass spectrometry (LC-MS/MS) analytics to create new assays for the diagnosis of cardiovascular diseases and bone metabolism disorders.
The goal is to develop a sensitive, reliable, qualitative and quantitative assay of complex samples, using Immundiagnostik’s antibody capabilities to optimize sample preparation and to efficiently isolate low level analytes in complex mixtures. Thermo Fisher’s proprietary, high-throughput Mass Spectrometric Immunoassay (MSIA) technology will also be applied, as well as the Thermo Scientific TSQ Vantage Triple Quadrupole Mass Spectrometer for quantitative analysis of small peptides, and Thermo Scientific Orbitrap Elite high-resolution accurate mass mass spectrometer to measure post-translational modifications. The goal is to develop assays that will achieve extremely selective identification of all molecular variations of peptides and proteins.
“We are impressed with Immundiagnostik’s antibody expertise, and are confident that the immunoaffinity-purification of proteins will take quantitative LC-MS/MS protein analysis to the next level,” said Jeff Zonderman, Thermo Fisher director of clinical and toxicology LC/MS.
“This type of work demands precise analytical tools,” said Dr. Franz Paul Armbruster, CEO of Immundiagnostik. “Thermo Fisher, with its recognized excellence in accurate mass and high resolution measurement, is the ideal partner for the advancement of our LC-MS/MS product line of assays."
As part of the collaboration, Immundiagnostik will provide a venue for demonstrating various Thermo Fisher technology applications. In addition, Immundiagnostik will utilize its academic and clinical network to identify diagnostic parameters, validate novel LC-MS/MS products and develop new assays for commercial distribution.
Thermo Fisher Scientific Inc. and QIAGEN N.V. announced that their boards of directors, as well as the managing board of QIAGEN N.V., have unanimously approved Thermo Fisher’s proposal to acquire QIAGEN for €39 per share in cash. The offer price represents a premium of approximately 23% to ... more
Thermo Fisher Scientific Inc. announced that it has completed its acquisition of FEI Company, Inc. a manufacturer of high-performance electron microscopy, for $107.50 per share in cash, or a total purchase price of approximately $4.2 billion. The completion of the transaction follows the re ... more
Aquion, Ion Chromatography, IC, anions, cations conductivity, ion analysis, Dionex, routine analysis, water testing, food and beverage testing, pharmaceutical counterions, water, waste water, ground water more
A new highly-configurable IC system offering freedom to run different methods, analyze complex samples and increase productivity and reduce downtime more
Gallery discrete analyzers are easy to use, automated systems that allow laboratories to simplify their testing enabling time and cost savings. more
Chromeleon 7.3 CDS: Built-in data security and stability tools, ensure business continuity for fastest return on investment - Why compromise? more
When addressing ion analysis challenges, there are sometimes more questions than answers. The ability to develop and run different methods for a single sample or for different samples is increasingly important for analytical laboratories. The Thermo Scientific™ Dionex™ ICS-6000 HPIC™ System ... more
Everyone knows that Thermo Scientific™ Chromeleon™ 7 Chromatography Data System (CDS) is easy-to-use and brings lab-friendly compliance. Now Chromeleon 7.3 CDS takes this to the next level while also delivering an IT-ready, scalable enterprise solution that is optimized for global deployment. more
Food safety is defined as “the absence of adverse health effects due to food contamination”. Contaminants are substances that have not been intentionally added to food. These substances may be present in food as a result of the various stages of its production, packaging, transport or holdi ... more
Organizations have made significant investments in enterprise and laboratory tools, technologies and solutions to help improve productivity, better manage data/information and optimize their business processes. However, the reality is that most comp more
- 1New NMR method enables monitoring of chemical reactions in metal containers
- 2Deep learning enables early detection and classification of live bacteria using holography
- 3analytica 2020: Great exhibitor resonance for the autumnal fair
- 4Merck acquires a French company
- 5Formation of quadruple helix DNA tracked in live human cells for the first time
- 6Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement
- 7Hurdle of microscopy overcome
- 8Microplastics transport metallic pollutants
- 9How smart, ultrathin nanosheets go fishing for proteins
- 10Biofilms - an invisible threat to food safety
- Is it time to abandon the Nobel Prize?
- Imperial and Tsinghua University launch seed fund for 'ambitious collaborations'
- Analytik Jena and BAM agree to cooperate in research
- Google provides open source library for quantum chemistry
- Adjustment of drug dose for rheumatoid arthritis by diagnostic method
- Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement
- Waters Corporation Names Udit Batra President and Chief Executive Officer
- How to map brain connections using DNA barcodes
- Listeria protein provides a CRISPR 'kill switch'
- Developing new techniques to improve atomic force microscopy